Alzheimer's biomarkers in adults with Down syndrome

Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)

NIH-funded research University of Pittsburgh at Pittsburgh · NIH-11392124

This project looks at brain scans, blood tests, and genetics in adults with Down syndrome to map when and how Alzheimer's-related changes appear.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-11392124 on NIH RePORTER

What this research studies

You would join a group of adults with Down syndrome who are followed over time with brain imaging, blood and other biological samples, and memory and thinking tests. The team compares amyloid, tau, and brain structure changes to patterns seen in typical late-onset Alzheimer's disease. They also search for genetic and other factors that speed up or slow memory decline in people with Down syndrome. Multiple centers share data and methods to make results reliable and useful for future treatment trials.

Who could benefit from this research

Good fit: Adults with Down syndrome (typically aged 21 and older), with or without memory concerns, are the intended participants.

Not a fit: People without Down syndrome or children and adolescents under the adult age cutoff would not be eligible and are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, this work could help detect Alzheimer's earlier in people with Down syndrome and guide future prevention or treatment trials tailored to them.

How similar studies have performed: Biomarker studies in Alzheimer's and in Down syndrome have produced informative results before, and this consortium expands and standardizes those approaches across sites.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.